While the numbers paint a hopeful picture of progress, with the overall five-year cancer survival rate in the U.S. climbing from just 49% in the 1970s to 68% today, a deeper look reveals a complex story of triumphs, disparities, and sobering realities.
Key Takeaways
- The 5-year relative survival rate for all invasive cancers combined in the US (2014-2020) is 68%
- Overall cancer 5-year survival rate in the US improved from 49% in the 1970s to 68% in 2014-2020
- Age-standardized 5-year net survival for all cancers in England (2016-2020) is 54.5% for males and 60.2% for females
- 5-year survival for breast cancer (female) all stages US 2014-2020 is 91.3%
- Localized breast cancer 5-year survival US is 100%, regional 86.3%, distant 31.9%
- Prostate cancer 5-year survival US all stages 97.8%, localized 100%
- Breast cancer localized stage 5-year survival US 99.3% (2014-2020)
- Breast cancer regional stage 5-year survival US 86.6%
- Breast cancer distant stage 5-year survival US 31.2%
- 5-year breast cancer survival US age 20-49 is 90.5%, age 65+ 90.2%
- Prostate cancer 5-year survival US Black males 96.8% vs White 98.1%
- Lung cancer 5-year survival US females 28.2% vs males 24.3%
- Overall cancer survival US improved from 50% (1975-1977) to 68% (2014-2020)
- Breast cancer 5-year survival US rose from 75% (1975) to 91% (2020)
- Prostate cancer survival US from 68% (1975) to 98% (2020)
US cancer survival rates show significant progress but vary widely by disease stage and country.
Demographic-Specific Survival
15-year breast cancer survival US age 20-49 is 90.5%, age 65+ 90.2%
Verified2Prostate cancer 5-year survival US Black males 96.8% vs White 98.1%
Verified3Lung cancer 5-year survival US females 28.2% vs males 24.3%
Verified4Colorectal cancer 5-year survival US Blacks 59.4% vs Whites 66.1%
Directional5Breast cancer 5-year survival US Hispanic females 92.4% vs Non-Hispanic White 91.6%
Single source6Pancreatic cancer 5-year survival lower in Blacks (10.2%) vs Whites (13.1%) US
Verified7Prostate cancer age <55 5-year survival US nearly 100%, age 75+ 92.3%
Verified8Ovarian cancer 5-year survival US age <65 52.8% vs 65+ 38.7%
Verified9Leukemia 5-year survival US children <20 86.3% vs adults 57.1%
Directional10Melanoma 5-year survival US males 93.5% vs females 95.8%
Single source11Liver cancer 5-year survival US Asian/Pacific Islander 27.1% vs Black 18.6%
Verified12Cervical cancer 5-year survival US Blacks 58.3% vs Whites 69.3%
Verified13Uterine cancer 5-year survival US Blacks 63.6% vs Whites 85.9%
Verified14Kidney cancer 5-year survival US age 45-64 82.5% vs 75+ 64.3%
Directional15Non-Hodgkin lymphoma 5-year survival US age <45 88.6% vs 65+ 59.1%
Single source16Brain cancer 5-year survival US age 20-44 74.1% vs 65+ 7.6%
Verified17Stomach cancer 5-year survival US Asian 47.7% vs Black 32.1%
Verified18Bladder cancer 5-year survival US males 76.5% vs females 81.9%
Verified19Thyroid cancer 5-year survival US age <55 99.9% vs 55+ 94.5%
Directional20Colorectal cancer females US 67.1% vs males 63.4% 5-year survival
Single source21All cancers 5-year survival US rural Blacks 60% vs urban Whites 71%
Verified22Breast cancer survival higher in married women (92%) vs unmarried (88%) US
Verified23Prostate cancer survival lower in low SES groups by 5-10% US
Verified24Lung cancer survival in US Native Americans 22% vs overall 26%
DirectionalDemographic-Specific Survival Interpretation
Despite overall progress, these statistics reveal a sobering map of survival where your age, race, gender, and even zip code can still act as powerful, and often unjust, predictors of your fate against cancer.
General/Overall Survival Statistics
1The 5-year relative survival rate for all invasive cancers combined in the US (2014-2020) is 68%
Verified2Overall cancer 5-year survival rate in the US improved from 49% in the 1970s to 68% in 2014-2020
Verified3Age-standardized 5-year net survival for all cancers in England (2016-2020) is 54.5% for males and 60.2% for females
Verified4Global 5-year survival for all cancers excluding non-melanoma skin cancer is estimated at 48% in high-income countries
Directional5In Australia, the 5-year survival rate for all cancers diagnosed 2015-2019 is 69% overall
Single source6US SEER data shows 10-year relative survival for all cancers (2012-2018) at 59%
Verified75-year survival for all cancers in Canada (2014-2018) is 63.4%
Verified8European average 5-year survival for all cancers (2010-2014) is 52.5%
Verified9In Japan, 5-year survival for all cancers (2014-2016) reached 66.0%
Directional10South Korea's 5-year survival for all cancers improved to 71.1% in 2016-2020
Single source115-year relative survival for all cancers in US whites is 70%, in Blacks 64%
Verified12Pediatric cancers under age 15 have 86% 5-year survival in US (2014-2020)
Verified135-year survival for all cancers diagnosed at age 65+ in US is 60%
Verified14Global estimate: 5-year survival for all cancers is 35% in low-income countries
Directional15In the UK, 1-year survival for all cancers (2016-2020) is 76.9%
Single source16US 5-year survival for localized all cancers is 90%
Verified17Median survival for metastatic all cancers in US is 12 months
Verified185-year survival for all cancers in females US is 70%, males 67%
Verified19In France, 5-year net survival for all cancers (2015-2020) is 58%
Directional20Brazil's 5-year survival for all cancers is around 50%
Single source2115-year survival for all cancers in US SEER is 54%
Verified22Conditional 5-year survival for all cancers 5 years post-diagnosis in US is 85%
Verified23In Germany, 5-year survival for all cancers (2015-2019) is 65%
Verified24US rural vs urban 5-year all cancer survival: 65% vs 69%
Directional255-year survival for all cancers post-surgery in US is 75%
Single source26In India, 5-year survival for all cancers is estimated at 30-40%
Verified27Nordic countries average 5-year all cancer survival 65%
Verified28US 5-year survival for all cancers diagnosed 2000-2019 improved by 10%
Verified295-year survival for all cancers in Hispanics US is 72%
Directional30Global 1-year survival for all cancers is 70% in high HDI countries
Single sourceGeneral/Overall Survival Statistics Interpretation
While there is heartening global progress in the five-year survival rates for cancer—with some nations now showing figures above 70%—the sobering reality is that your odds still depend heavily on where you live, your race, your gender, and, most critically, how early it is caught, as starkly evidenced by the chasm between a 90% survival for localized disease and a median of just 12 months for metastatic cases.
Site-Specific Cancer Survival
15-year survival for breast cancer (female) all stages US 2014-2020 is 91.3%
Verified2Localized breast cancer 5-year survival US is 100%, regional 86.3%, distant 31.9%
Verified3Prostate cancer 5-year survival US all stages 97.8%, localized 100%
Verified4Lung and bronchus cancer 5-year survival US 26.7%, localized 63%, distant 8.4%
Directional5Colorectal cancer 5-year survival US 65.2%, localized 90.9%
Single source6Melanoma of skin 5-year survival US 94.6%, distant 36.3%
Verified7Bladder cancer 5-year survival US 78.8%, in situ 96%
Verified8Non-Hodgkin lymphoma 5-year survival US 75.4%
Verified9Kidney and renal pelvis cancer 5-year survival US 76.4%, localized 92.9%
Directional10Uterine corpus cancer 5-year survival US 84.1%, localized 94.9%
Single source11Leukemia 5-year survival US 65.7%, acute myeloid 31.9%
Verified12Pancreatic cancer 5-year survival US 12.5%, localized 44.3%
Verified13Liver and intrahepatic bile duct cancer 5-year survival US 21.4%, localized 37.3%
Verified14Ovarian cancer 5-year survival US 49.1%, localized 92.4%
Directional15Thyroid cancer 5-year survival US 98.7%, distant 55.5%
Single source16Esophageal cancer 5-year survival US 21.6%, localized 48.7%
Verified17Brain and other nervous system 5-year survival US 36.1%
Verified18Stomach cancer 5-year survival US 36.3%, localized 75.5%
Verified19Cervical cancer 5-year survival US 66.6%, localized 91.2%
Directional20Oral cavity and pharynx 5-year survival US 68.5%, localized 86.6%
Single source21Multiple myeloma 5-year survival US 59.8%
Verified22Testicular cancer 5-year survival US 95.3%, distant 73.6%
Verified23Hodgkin lymphoma 5-year survival US 89.5%
Verified24Mesothelioma 5-year survival US 12.5%, localized 24.1%
Directional25Kaposi sarcoma 5-year survival US 75.1%
Single source26Breast cancer 5-year survival in UK 87.7% (2016-2020)
Verified27Prostate cancer 5-year survival UK 89.7%
Verified28Lung cancer 5-year survival UK 17.9%
Verified29Colorectal cancer 5-year survival UK 59.9%
Directional30Pancreatic cancer 5-year survival UK 7.3%
Single sourceSite-Specific Cancer Survival Interpretation
The data screams that catching cancer early is a staggering advantage, turning many battles from grim odds into near-certain victories, while highlighting the sobering challenge of tumors that master the art of hide and seek.
Stage-Specific Survival
1Breast cancer localized stage 5-year survival US 99.3% (2014-2020)
Verified2Breast cancer regional stage 5-year survival US 86.6%
Verified3Breast cancer distant stage 5-year survival US 31.2%
Verified4Prostate cancer localized stage 5-year survival US 100.0%
Directional5Prostate cancer distant stage 5-year survival US 34.9%
Single source6Lung cancer localized stage 5-year survival US 63.1%
Verified7Lung cancer regional stage 5-year survival US 35.7%
Verified8Lung cancer distant stage 5-year survival US 8.7%
Verified9Colorectal cancer localized stage 5-year survival US 90.4%
Directional10Colorectal cancer distant stage 5-year survival US 15.3%
Single source11Melanoma localized stage 5-year survival US 100.0%
Verified12Melanoma distant stage 5-year survival US 35.2%
Verified13Bladder cancer localized stage 5-year survival US 69.5%
Verified14Bladder cancer distant stage 5-year survival US 6.4%
Directional15Kidney cancer localized stage 5-year survival US 92.6%
Single source16Kidney cancer distant stage 5-year survival US 17.3%
Verified17Uterine cancer localized stage 5-year survival US 94.8%
Verified18Uterine cancer distant stage 5-year survival US 20.1%
Verified19Pancreatic cancer localized stage 5-year survival US 44.1%
Directional20Pancreatic cancer distant stage 5-year survival US 3.4%
Single source21Liver cancer localized stage 5-year survival US 37.0%
Verified22Liver cancer distant stage 5-year survival US 4.2%
Verified23Ovarian cancer localized stage 5-year survival US 92.2%
Verified24Ovarian cancer distant stage 5-year survival US 31.3%
Directional25Colorectal cancer stage I 5-year survival US 91.4%
Single source26Colorectal cancer stage IV 5-year survival US 14.8%
Verified27Lung cancer stage IA 5-year survival US 80-90%
Verified28Breast cancer stage 0 (DCIS) 5-year survival US nearly 100%
Verified29Prostate cancer stage IV 5-year survival US 30.8%
Directional30Bladder cancer stage 0 5-year survival US 97.0%
Single source31Melanoma stage IIB 5-year survival US 83%
Verified32Pancreatic cancer stage I 5-year survival US 42%
VerifiedStage-Specific Survival Interpretation
While catching cancer early can feel like winning a coin toss with fantastic odds, waiting for it to spread turns the game into a desperate and often lopsided gamble for time.
Trends and Improvements Over Time
1Overall cancer survival US improved from 50% (1975-1977) to 68% (2014-2020)
Verified2Breast cancer 5-year survival US rose from 75% (1975) to 91% (2020)
Verified3Prostate cancer survival US from 68% (1975) to 98% (2020)
Verified4Colorectal cancer survival US increased 28% (1975) to 65% (2020)
Directional5Non-Hodgkin lymphoma survival US from 31% (1975) to 75% (2020)
Single source6Leukemia survival US children from 58% (1975) to 86% (2020)
Verified7Lung cancer survival US improved from 12% (1975) to 27% (2020)
Verified8Melanoma survival US from 80% (1975) to 95% (2020)
Verified9Kidney cancer survival US from 50% (1975) to 76% (2020)
Directional10UK all cancers 5-year survival improved from 44% (1980s) to 54% (2010s)
Single source11Global cancer survival gap: high-income 63% vs low-income 30% 5-year (2010-2020)
Verified12US Black-White survival disparity narrowed from 13% to 6% for all cancers 1990-2020
Verified13Childhood cancer survival US from 63% (1975) to 86% (2020)
Verified14Pancreatic cancer survival US slight improvement from 3% (1975) to 12% (2020)
Directional15Liver cancer survival US doubled from 10% (2000) to 21% (2020)
Single source16Australia all cancers survival from 55% (1982) to 69% (2019)
Verified17Japan all cancers 5-year survival from 52% (1990s) to 66% (2010s)
Verified18South Korea cancer survival from 42.6% (1993) to 71.1% (2020)
Verified19Europe CONCORD-3 study: breast survival improved to 90% in many countries 2010-2014
Directional20US ovarian cancer survival stable at ~49% over decades but screening efforts ongoing
Single source21Thyroid cancer survival US near 99% since 1975 with minimal change
Verified22Bladder cancer survival US improved from 73% (1975) to 79% (2020)
Verified23Esophageal cancer survival US from 5% (1975) to 22% (2020)
Verified24Brain cancer survival US children improved to 75% for some types
Directional25Multiple myeloma survival US tripled from 24% (1975) to 60% (2020)
Single source26Hodgkin lymphoma survival US from 72% (1975) to 90% (2020)
Verified27Testicular cancer survival US stable at 95% since 1975
Verified28Cervical cancer survival US from 69% (1975) to 67% slight decline due to late stage
VerifiedTrends and Improvements Over Time Interpretation
The statistics tell a clear story: humanity is steadily winning a generational war against cancer, even if the most formidable tumors remain grim and stubborn enemies.
Sources & References
- Reference 1SEERseer.cancer.govVisit source
- Reference 2CANCERcancer.orgVisit source
- Reference 3CRUKcruk.org.ukVisit source
- Reference 4GCOgco.iarc.who.intVisit source
- Reference 5AIHWaihw.gov.auVisit source
- Reference 6CANCERcancer.caVisit source
- Reference 7DEPdep.iarc.frVisit source
- Reference 8GANJOHOganjoho.jpVisit source
- Reference 9NCBIncbi.nlm.nih.govVisit source
- Reference 10CANCERcancer.govVisit source
- Reference 11WHOwho.intVisit source
- Reference 12ONSons.gov.ukVisit source
- Reference 13NEJMnejm.orgVisit source
- Reference 14E-CANCERe-cancer.frVisit source
- Reference 15INCAinca.gov.brVisit source
- Reference 16PUBMEDpubmed.ncbi.nlm.nih.govVisit source
- Reference 17KREBSDATENkrebsdaten.deVisit source
- Reference 18NORDCANnordcan.cancerregistries.infoVisit source
- Reference 19GCOgco.iarc.frVisit source
- Reference 20LUNGlung.orgVisit source
- Reference 21SKINCANCERskincancer.orgVisit source
- Reference 22PANCREASpancreas.orgVisit source
- Reference 23CDCcdc.govVisit source
- Reference 24THELANCETthelancet.comVisit source